NZ Marine Biotech ($20M MC - High Growth Prospect), page-468

As I started this thread, I want to note that I have greatly reduced my position in NZS, partly due to portfolio management practices and being too NZS heavy, but also due to the rocket of a shareprice/fair value of NZS. I feel that the NZS market cap rising $15-20M in the past two days was unjustified for current business activities, I have therefore reduced my holdings by 80%. I believe its falling back down to fair value now, although selling at the oppies equivalent of 7c+ heads was what I saw fit with potential for reentering at a lower price. I believe NZS is due a CR soon, as they have relatively small cash holdings, so I will strongly consider rebuilding my position upon that CR happening.

I remain bullish for NZS prospects following this CR and I remain holding a position in NZS, although as stated in the original post, I was expecting a 5.5c rerate over the next quarter, this far surpassed this expectation, I would be ignoring a large percentage of my financial education by not adjusting my portfolio. I now turn my attention to a company that has just finished a CR and is about to go through a similar rerate and is undervalued. It makes sense to adjust accordingly from NZS to a company such as that. As I still hold a % in NZS I will remain on threads, although I thought it would be honest of me to explain my position.

Cheers guys, alot of us made some serious money over the past 3 weeks. Glad we didnt sell sub 3.